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Abstract. Macrophages and B-lymphocytes express
two major isoforms of Fc receptor (FCRII-B2 and
FcRll-B1) that exhibit distinct capacities for endocy-
tosis. This difference in function reflects the presence
of an in-frame insertion of 47 amino acids in the cyto-
plasmic domain of the lymphocyte isoform (FcRII-BI)
due to alternative mRNA splicing. By expressing wild
type and mutant FcRII cDNAs in fibroblasts, we have
now examined the mechanism by which the insertion
acts to prevent coated pit localization and endocytosis.
We first identified the region of the FcRII-B2 cytoplas-
mic domain that is required for rapid internalization.
Using a biochemical assay for endocytosis and an im-
muno-EM assay to determine coated pit localization
directly, we found that the distal half of the cytoplas-
mic domain, particularly a region including residues
18-31, as needed for coated pit-mediated endocytosis.
F
c receptors for IgG (FcR)' are members of a large
multigene hunily that mediates diverse functions crit-
ical to the cellular immune response in various cell
types (Mellman, 1989; Ravetch and Kinet, 1991). One ofthe
best characterized of these receptors is the product of the
murine FcRII gene. This receptor is specific for multivalent
IgG-antigen complexes and is expressed as two major iso-
forms, FcRII-B1 and -B2, in macrophages and lymphocytes,
respectively (Hibbs et al., 1986; Lewis et al ., 1986; Ravetch
et al ., 1986). The two receptors have identical extracellular
and membrane spanning domains, but differ in their cyto-
plasmic tails due to cell-type specific alternative mRNA
splicing (Qiu et al., 1990). While the macrophage FcRII-B2
isoform has a cytoplasmic domain of only 47 amino acids,
the B-cell FCRII-Bl isoform contains an in-frame insertion
of 47 additional amino acids. The insert occurs at a site six
residues from the membrane.
By stably transfecting the two FCRII isoforms into
receptor-negative fibroblasts, we found that these variations
in the cytoplasmic domain are associated with functional
differences between the two receptors (Miettinen et al.,
1989). WhileFcRII-B2 was foundto mediate the efficienten-
docytosis and delivery to lysosomes ofligand-receptor com-
plexes via clathrin-coated pits, FcRII-BI was almost com-
1. Abbreviation used in this paper: FcR, Fc receptor.
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Elimination of the tyrosine residues at position 26 and
43, separately or together, had little effect on coated
pit localization and a partial effect on endocytosis of
ligand. Since the FCRII-Bl insertion occurs in the
membrane-proximal region of the cytoplasmic domain
(residue 6) not required for internalization, it is un-
likely to act by physically disrupting the coated pit lo-
calization determinant. In fact, the insertion was found
to prevent endocytosis irrespective of its position in
the cytoplasmic tail and appeared to selectively ex-
clude the receptor from coated regions. Moreover,
receptors bearing the insertion exhibited a
temperature- and ligand-dependent association with a
detergent-insoluble fraction and with actin filaments,
perhaps in part explaining the inability of FcRII-Bl to
enter coated pits.
pletely deficient at coated pit localization and mediated
ligand internalization even less efficiently than a tail-minus
FcRII mutant. This difference also appears to correlate with
the relative abilities of endogenous FcRII in macrophages
and B-lymphocytes to mediate the endocytosis of IgG-com-
plexes (Amigorena, S., C. Bonnerot, D. Choquet, G. Raposo,
J.G. Guillet, C. Sautes, W H. Fridman, J. Drake, W Hun-
ziker, P Webster, and 1. Mellman, manuscript submitted for
publication; Mellman and Plutner, 1984; Miettinen et al.,
1989). Thus, the cytoplasmic tail insertion in FcRII-BI
somehow acts to disrupt the receptor's ability to localize in
coated pits. The insert also introduces several serine phos-
phorylation sitesthat are used in conjunction with FcRII-Bl-
mediated regulation of B-cell activation (Hunziker et al.,
1990) . Phagocytosis, however, does not seem to require a
functional coated pit localization domain since both FCRII-
Bl and FcRII-B2 were able to mediate internalization ofIgG-
coated parasites in transfected CHO cells (Joiner et al.,
1990) .
To understand how alternative mRNA splicing regulates
Fc receptor-mediated endocytosis, it is first necessary to
identify what region or regions of the FcRl1-B2 cytoplasmic
tail are required for coated pit localization. Most plasma
membrane receptors studied thus fár have been shown to
selectively accumulate in coated pits due to the presence of
a tyrosine-containing recognition determinant (Alvarez et
875al., 1990; Davis et al., 1987; Jing et al ., 1990; Lazarovits,
1988; Lobelet al., 1989; McGraw andMaxfield, 1990). The
FcRII-B2 cytoplasmic tail contains two tyrosine residues,
the sequence surrounding oneof whichat least superficially
resembles sequences found near the critical tyrosines of
othercoated pit receptors (Ktistakis et al., 1990). This tyro-
sine also falls within aregion of high homology between the
murine andhumanreceptors(Brooks et al ., 1989; Stengelin
et al., 1988; Stuart et al., 1987, 1989), furthersuggesting its
functional importance. We now show that although the ho-
mologous region is at leastoneelementoftheFcRII-B2 cyto-
plasmic tail that is required for rapid endocytosis, neither
of thetwotyrosine residues areessential forcoated pit local-
izationandonly partially required forinternalization. More-
over, ourdata suggestthat thecytoplasmic domain insertion
characteristic ofFCRII-BI does notblockendocytosisby dis-
ruptingthecoated pit localization domain, but actively pre-
vents coated pit localization, at leastin part,by tethering the
receptor to the cytoskeleton.
Materials andMethods
Transient Expression in COS1 Cells
Cells were grown in monolayer cultures in DME containing 5 % FBS. One
day before transfection cells were plated at a density of 5 x 105 cells/35
mm well. Cells were transfected using the DEAF-dextran method (Adams
and Rose, 1985) with either pJC119R (Miettinen et al., 1989; Sprague et
al., 1983), or SRa (Takebe et al., 1988) as expression vector. The FcR
cDNAs were ligated intotheunique EcoRI site ofrespective vector. All ex-
periments were performed 18-24 h after the transfection.
Stable Expression in CHO Cells
Permanent FcRII-expressing CHO cell lines were produced after transfec-
tion using the amplifiable expression vectorpFRSV as describedpreviously
(Miettinen et al., 1989). Transfected cells were maintained as monolayer
cultures in a selection medium containing 10-100 pM methotrexate and 4
jug/ml folic acid in a-MEM supplemented wit. 5 % FBS. After thecellshad
reached a stable growth rate in 10 AM methotrexate, 3-5% of the highest
expressing cells were collected using a fluorescence-activated cell sorter
(FAGS Star, Becton Dickinson Microbiology Sys., Cockeysville, MD) as
follows: cells grown in suspension culture were incubated at a density of
2 x 105 cells/ml at 0°C for 90 min with 20 14g/ml 2ÁG2 IgG, a rat mAb
against FcRII; the cells were washed twice with a-MEM containing 8 %
FBS and incubated at 0°C for 30 min with fluorescein-conjugated rabbit
anti-rat IgG; after washing, the cells were resuspended in PBS at 2 x 105
cells/ml and finally sorted under sterile conditions using window settings
of 3.8 or 4.25 log units, depending on expression level. Nontransfected
CHO cells were used as negative controls.
Site-directed Mutagenesis and Polymerase
Chain Reaction
The FcRII-B2 and FeRII-BI cDNAs were cloned in the T7 orientation to
the EcoRI site of Bluescript SKI. Single stranded template was prepared
using M13 K07 helper phage. In vitro mutagenesis was performed as de-
scribed using the Bio-Rod mutagenesis kit (Bio-Rod Laboratories, Cam-
bridge, MA) (Kunkel et al., 1987). The following synthetic oligonucleotides
were used as primers to generate the mutations. The oligonucleotides 5'-T
ACGATC ACC GCT TCA CTT CTC A-3' and 5'-CA GAG CAT GAT GCG
CAG AAC CAC ATT TAG-3' were designed to change the FcRII-B2 cyto-
plasmic tail tyrosines in positions 26 (TAC) and 43 (TAC), respectively, to
alanines (GCT and GCG) (Fig. 1). The double tyrosine mutant in B2 was
generated by makingasingle-strandedtemplatefromthe B2 cDNA contain-
ing themutation inposition 26andthen priming withthe second oligonucle-
otide primer. An Mlul restriction site was generated just before the stop
codon in the wild type FrRII-B2 cDNA by using 5'-GAT TAC CAG AAC
ACG CGT TAG TCT CCC TTG-3' as primer. This mutation changed the
two last amino acids, histidine and isoleucine, to threonine and arginine.
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All mutations were transformed into Fscherichia coli C600 and the muta-
tions were confirmed by sequencing using the Sanger dideoxy method
(Sanger etal., 1977). To ensure that no othermutationshadbeen introduced
during the in vitro mutagenesis, the entire transmembrane and cytoplasmic
domains of respective constructs were also sequenced.
The construction of the FCRII-B2 tail-minus deletion mutant has been
described elsewhere (Miettinen et al., 1989). The FcRII-B2 CT31 and
C718 deletion mutants were constructed essentially according to the
Stratagene manual. An EcoRl/HincII fragment ofthe FcRII-B2 cDNA was
cloned into Bluescript KS' in T7 orientation. The plasmid was linearized
with HincII and KpnI and digested first 1-5 min at 23°C with Exonuclease
III followed by a 30-min digestion at 37°C with mung bean nuclease. The
overhangs were filled in, and the plasmid was religated using an Xbal stop
codon linker. Clones were screened by digestion ofminipreps with Xbaland
the clones ofinterestwere identified by sequencing. In both CT31 andCT18
the last amino acid (Thr18 and His31) was preserved.
The FcRII-BI insert cDNA with overhanging MluI restriction sites (151
bp) was synthesized by polymerase chain reaction (Saiki et al., 1988) using
the following pair of primers: 5'-C ACT ACG CGT GCT CTC CCA GGA
AAC-3' and 5'-A CTG ACG CGT GTA TGG GCT GCT GCT TTG-3'
(M1ul-site underlined). The reaction was done using a PCR-kit (Perkin El-
mer Corp., Norwalk, CT) and a cycler (Techne Inc., Princeton, NJ).
Fluorescence Microscopy
Cells on cwerslips were incubated for 2 h at 0°C with 20 pg/ml IgG com-
plexes. The complexes, consisting of rabbit anti-2,4-DNP IgG and DNP-
modified BSA (DNP-BSA) combined ata molarratio of2.5:1, were formed
as previously described (Mellman and Plutner, 1984) . After washing, the
cells were incubated for 30 min at 37°C, fixed, and prepared for im-
munofluorescence essentially as previously described (Miettinen et al.,
1989). To visualize F-actin, cells were incubated afterfixation and permea-
bilization with rhodamine-conjugated phalloidin (Molecular Probes Inc.,
Eugene, OR).
Endocytosis Assay
Cells were grown to -70% confluency in 24-well plastic dishes and in-
cubated for 20 min on iceand 30 min at 37°C beforetheexperiment to max-
imizecell spreading. HRP-IgG complexes were formed at 37°C for 30min
using 21 pg/ml affinity-purified rabbit anti-HRP IgG and 5 pg/ml HRP
(SigmaChemicalCo., St. Louis, MO). Cells wererinsedonce with ice-cold
binding buffer (PBS containing 0.2% BSA, 1 mg/mlglucose, and 1 mM so-
dium pyruvate) andsubsequently labeled with HRP-IgG complexes diluted
1:20 withbindingbuffer. Afterexactly 45 min on ice, thecells were washed
four times with binding buffer and then incubated at 37°C in prewarmed
binding buffer for various times. The cells were then cooled on ice and
rinsed twice with PBS. 200 Al PBS t 0.2596 Triton X-100 was then added
and incubated for 10 min on ice. 500 AI assay buffer (PBS containing 0.75
mg/ml o-phenylenediamine dihydrochloride and 0.023% hydrogen perox-
ide) was then added to detect total (+ detergent sample) vs. cell surface-
bound (- detergent sample) HRP. The samples were incubated for 20 min
(during which time the reaction remained linear) and then stopped by add-
ing 300 Al 1 M HCl. 200 Al aliquots were transferred to a 96-well ELISA
plate and the absorbance at 492 nm measured using a Titertek Multiscan
plate reader (Flow Labs, McLean, VA). The amount of internalized ligand
was determined by calculating the difference in absorbance measured with
and without Triton X-100 as described previously (Drake et al., 1989).
ImmunogoldLabeling and EM
Gold sols (7-9 nm) were made by tannic acid-citratereduction ofgold chlo-
ride (Slot and Geuze, 1985). The gold-DNP/BSA complexes were formed
and purified as described (Miettinen et al., 1989; Ukkonen et al., 1986).
Subconfluent CHO monolayers in 22-mm wells were incubated with 20
pg/ml gold-IgGcomplexes for2 hat 0°C. Cellswere washedwith coldPBS
and dipped into prewarmed medium for 1.5 min. After the brief incubation
at 37°C the cells were dippedinto cold PBS and processed for EM asprevi-
ously described (Ukkonen et al., 1986). Random micrographs of cells were
taken at 10,000x with a JEM-100 CX electron microscope. Gold particles
were counted from micrographs and in some cases (B2 A26, B2/Bl-R, and
B2/Bl-W) directly from the screen. For each cell line, the gold particles
were counted from a total ofat least 0.75 mm ofcell surface contour length
determined using a morphometer (Carl Zeiss, Inc., Thornwood, NY). The
data shown for the coated pit localization ofFcRII-Bl, B2, and -tail-minus
are in part from a previous publication (Miettinen et al., 1989) .
8767riton Extractions and Immunoprecipitations
A subconfluent monolayer of cells on a 6-cm dish was labeled overnight
with 0.4 mCi/ml [35S]-cysteine in cysteine-free a-MEM containing 8% di-
alyzed heat-inactivated FBS and 10 mM Hepes, pH 7.2. The labeling was
terminated by rinsing the cells with PBS and the cells were chased for 1 h
in complete a-MEM containing 8% heat-inactivated FBS. The cells were
then incubated for 30 min with or without ligand (20 14g/ml IgG-complex
or rabbit anti-FcR serum 1:100) on ice or at 37°C. After rinsing with cold
PBS the cells wereextracted for 10 min at 0°C in 1 ml "cytoskeleton buffer"
(CSK) (0.5 % Triton X-100, 10 mM K-PIPES [pH 6.8], 100 mM NaCl, 300
mM sucrose, 3 mM MgC12, and 1 mM PMSF) as described by Fey et al.
(1984). The plates were scraped usinga rubber policepersonandthe soluble
and insoluble fractions were separated by a 1-min spin in a centrifuge (Ep-
pendorfInc., Freemont, CA). The Triton X-100 insoluble fraction was solu-
bilized in 100 pl buffer containing 1% SDS, 50 mM Tris-HCL (pH 8.8),
5 mM EDTA, and 1 mM PMSF, and the volume was adjusted to 1 ml with
CSK. After adding SDS to the soluble fraction (0.1% final concentration),
both fractions were immunoprecipitated using 3 pl rabbit anti-FcR serum
(2 h, 4°C) followed by 10 pl ofa 10% (wt/vol) suspension offixed Staphylo-
coccus aureus cells (Zysorbin, Zymed Labs. Inc., South San Francisco,
CA) that had been previously washed in PBS containing 1 mg/ml BSA and
0.5% Triton X-100. After precipitation, the cells were washed with RIPA
buffer (10 mM Tris-HCI, pH 7.4, 0.1% SDS, 1% deoxycholate, 1% NP-40,
and 0.15 M NaCI) and resuspended in 5 141 buffer containing 0.2 M sodium
phosphate (pH 8.2), 1% SDS, and 1% mercaptoethanol. The samples were
denatured by heating to 100°C for 3 min, and NP-40 in 0.2 M sodium phos-
phate (pH 8.2) was added to give a final concentration of 0.2% SDS and
1.4% NP-40. Samples were incubated for 16 h at 37°C with 0.15-0.2 units
recombinant N-glycanase (Genzyme Corp., Cambridge, MA), mixed with
an equal volume of2x electrophoresis sample buffer, heated to 100°C for
3 min and run on a 15% SDS-polyacrylamide gel. After staining and de-
staining, the gel was soaked in0.2 M sodium salicylate (pH 7.2), dried, and
exposed on Kodak X-Omat film (Eastman Kodak Co., Rochester, NY) at
-75°C. After developing the X-ray film, the intensity of the bands was
quantified using an image processor (Kodak Visage 2000, Eastman Kodak
Co.) supported by a Sun Microsystems workstation.
Results
A Conserved Tyrosine-containing Region
ofthe Fc Receptor Cytoplasmic Tail Is Requiredfor
Efcient Endocytosis
We have previously shown that efficient endocytosis ofligand
by FCRÜ-B2 requires the receptor's cytoplasmic domain,
since a tail-minus deletion mutant was internalized with re-
duced efficiency and localized in coated pits with a 10-15-
fold lowerfrequency than the wild type receptor (Miettinen
et al ., 1989). To examine the region(s) ofthe cytoplasmic do-
main that are required ft)r coated pit localization and rapid
endocytosis, a series of deletion mutations was made.
Two
of these deletion mutants, CT31 and CTl8, with 31 and 18
Bl wt
B2 wt
B2/B1-R
B2/B1-W
Tail-minus CT18 C'33
4
￿
4 O 4
￿
0
KKKQVPDNPPDLEEAAKTEAENTITYSLLKHPEALDEETEHDYQNHI
KKKQVPDNPPDLEEAAKTEAENTITYSLLKHPEALDEETEHDYQNTRVWAAACWLQSM4RPWADRH
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residues remaining of the 47 amino-acid cytoplasmic do-
main,respectively (Fig. 1), were inserted into an SV40-based
expression vector for transient expression in COS-1 cells.
One day after transfection, cells were incubated on ice with
ligand consisting of rabbit anti-DNP IgG:DNP-BSA (IgG-
complexes) and then shifted to 37°C for 30 min to allow en-
docytosis. Cells were then prepared for immunofluorescence
microscopy. As shown in Fig. 2, cells transfected with the
wild type FCRII-B2 had a vacuolar staining pattern with only
some staining on the cell surface (Fig . 2 A). Similarly, cells
expressing the CT31 deletion mutant which lacks the last 16
amino acids of the cytoplasmic tail, exhibited an intracellu-
lar staining pattern resembling that of FcRII-B2 (Fig. 2 B).
In contrast, in cellsexpressing the CT18 mutant, most of the
staining was found on the cell surface (Fig. 2 C), similar to
the pattern exhibited by cells transfected with the tail-minus
mutant (Miettinen et al., 1989) . These results suggested that
the domain for rapid endocytosis was at least partly located
between amino acids 18 and 31. This region corresponds to
the only stretch ofconserved amino acids between FCRII-B2
and its human homologue hFcRII-C; the human and mouse
receptors are 85 % identical throughout this sequence (11 out
of 13 amino acids), but less conserved (35%) elsewhere in
the cytoplasmic tail .
Tyrosine Residues in the FcRII-B2 Tail Are
Incompletely Requiredfor Efficient Endocytosis
The cytoplasmic domain of FCRII-B2 contains two tyrosine
residues, the first (at position 26 [Y26]) being in the highly
conserved region required for rapid endocytosis. Y26 is also
located within a sequence that may have properties simi-
lar to coated pit localization domains in other receptors
(Ktistakis et al., 1990): a nonhelical structure containing
charged and/or polar residues to the amino-terminal side of
the tyrosine, and one or two charged or polar residues to the
carboxy-terminal side. To examine whether Y26 was needed
for coated pit localization and endocytosis, we changed it to
an alanine (A26) (Fig. 1) and transfected the mutant recep-
tor into COS-1 cells. Surprisingly, immunofluorescence in-
dicated that Y26 residue was not necessary for rapid endo-
cytosis. After30 min, much ofthe ligand in cells transfected
with the A26 mutant was in intracellular vesicles (Fig. 2 D)
similar to cells expressing the FcRII-B2 wild type.
To determine whether the second tyrosine at position 43
(Y43)might instead be the critical tyrosine, we produced two
additional mutants in which Y43 was changed to an alanine
KKKQVPALPGNPDHREMGETLPEEVGEYRQPSGGSVPVSPGPPSGLEPTSSSPYNPPDLEEAAKTEAENTITYSLLKHPEALDEETEHDYQNHI
KKKQVPDNPPDLEEAAKTEAENTI TYSLLKHPEALDEETEHDYQNTRALPGNPDHREMGETLPEEVGEYRQPSGGSVPVSPGPPSGLEPTSSSPYTR
Figure 1. Amino acid sequences of the cytoplasmic domains of wild type and mutant Fc receptors. The cytoplasmic domain sequences
of FCRII-131, -B2, and various mutants are shown in the single letter amino acid code. The underlined sequence in Bl shows the 47 amino
acid insertion. The tyrosine residues of the 132 receptor in positions 26 and 43 are marked with open circles and the deletion mutants
are marked with arrow heads. Additional or foreign amino acids in the B2/Bl-Rand B2/Bl-Wconstructs are indicated in bold; the location
of the Bl insert in B2/Bl-R is underlined.Figure 2 . Internalization ofIgG-complexes by COS-1 cells transiently expressing wild type or mutant FcRII-B2 . Cos4 cells were transfected
withcDNAs encoding FcRII-B2 or the indicated FcRII-B2 mutants using the pJC119R expression vector (Miettinen et al ., 1989 ; Sprague
et al ., 1983) . 24 h later, cells were incubated with 20,ug/ml IgG complexes for 2 h at 0°C. After washing with PBS-glucose, the cells
were warmed to 37°C for 30 min to allow internalization, fixed using paraformaldehyde-lysine-periodate, and permeabilized with saponin .
To visualize both surface-bound and internalized ligand, the permeabilized cells were stained with affinity-purified F(ab')2 fragments of
a fluorescein-conjugated goat anti-rabbit IgG. (A) FcRII-B2 ; (B) FcRII-B2 CT31 ; (C) FcRII-BN2 CT18 ; (D) FcRII-B2 A26 ; (E) FcRII-B2
A43 ; (F) FcRII-B2 A26&43.
(A43) alone or together with Y26 (A26/43 double mutant) .
When expressed transiently in COS-1 cells, both mutants
yielded staining patterns that were indistinguishable from
wild type FcRII-B2 and A26 (Fig . 2, E and F) . In each case,
most of the ligand was present in intracellular vesicles fol-
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lowing 30 min at 37°C . Relative to the CT18 deletion mu-
tant, little ligand remained on the cell surface as indicated
by immunofluorescence using nonpermeabilized cells (not
shown) .
To examine more quantitatively the effects of the various
878Table 1. Accumulation of Gold-labeled IgG complexes in Coated Pits and Coated Vesicles in Transfected CHO Cells
Transfected CHO cells grown in 22-mm tissue culture wells were incubated with 20 Ag/ml gold-conjugated IgG-complexes for 2 h at 0°C. Cells were washed
with cold PBS-glucose, rapidly warmed to 37°C for 1.5 min, immediately fixed in glutaraldehyde, and processed for EM as described in Materials and Methods.
Random micrographs were taken at 10,000x and the quantitation of gold particles on the plasma membrane, in coated pits and coated vesicles was performed
using prints enlarged to a final magnification of 25,000x . In each case, based on previous determinations, surface membrane corresponding to a total contour
length of at least 0.75 mm was analyzed. FcRII-B2 A26 and -B2/B1-W were quantified directly from the electron microscope screen. The data for FcRII-Bl, B2
and B2 tail-minus have in part been published earlier (Miettinen et al., 1989) and are in part new (direct quantitation from the electron microscope screen). The
number (or area) ofcoated pits per cell did not exhibit significant differences between cell lines. The number of receptors per cell was measured by determining
the binding of 1251-2.4G2 Fab at 0°C (Miettinen et al., 1989).
a
x
m c
d
é
Time (min)
Time (min)
Miettinen et al. Fc Receptor Entry into Coated Pits
---C>- B2
0 T-minus
--0 B2CT31
----- ￿B2CT18
-i- B1
B2
0 B2A26
--}- B2A4d
là B2A26&43
-0 B2
- 0-- B2B1R
-*- B2/BlW
Figure3 Internalization ofIgG-complexes in CHO cells expressing
wild type and mutant FcRII. CHO cells expressing wild type FcRH
or various receptor mutants were grown in 22-mm wells and al-
lowed tobind immune complexes consisting ofHRP/anti-HRP IgG
on ice. After washing, the cells were then rapidly warmed to 37°C.
mutations on endocytosis, we next determined the kinetics
of internalization using a biochemical assay. For this pur-
pose, stable FcRII-expressing cell lines were generated by
transfecting CHO cells with an amplifiable expression vector
(pFRSV) and selected in increasing concentrations of
methotrexate (Miettinen et al ., 1989). Cells were then sorted
in a fluorescence-activated cell sorter so that 3-5% of the
highest expressing cells were collected, yielding cell lines
expressing 0.7 x 105 to 7.4 x 105 receptors/cell, similar to
FcRII expression in macrophages (Table I). The cell lines
were screened for FcRII-mediated endocytosis by im-
munofluorescence and found to yield patterns similar to
those obtained for the transiently expressing COS-1 cells
(Fig. 2).
To measure endocytosis, IgG immune complexes, formed
using HRP and affinity-purified anti-HRP, were bound on
ice, unbound ligand removed by washing, and the cultures
warmed to 37°C. After various time points, surface-bound
and intracellular HRP was determined by measuring HRP
activity in the absence or presence of Triton X-100, respec-
tively (Drake et al., 1989) . Internalized ligand was taken as
the difference between these two values. Binding and uptake
were judged to be specific since both signals were reduced
by >95% by including the anti-FcRII mAb 2 AG2 IgG, an
antibody that effectively blocks ligand binding to FcRII on
intact cells (Mellman and Unkeless, 1980; Mellman and
Plutner, 1984) . As shown in Fig. 3 A, cells transfected with
Atthe indicatedtimepoints, the cells were returned to ice and endo-
cytosisdetermined by measuring the amount oftotal vs. cell surface
HRPIgG as described in Materials and Methods. Internalized HRP
was calculated by subtracting the amount of surface HRP from the
amount oftotal HRP The amount ofHRP activity released into the
medium accounted for <5% of the initially-bound activity; 100%
ofthe initial HRP activity was recovered at each time point. All de-
terminations were performed in duplicate and the data represent the
means of 2-3 different experiments (±SD). (A) FcRII-B2 and the
B2 deletion mutants tail-minus, CT31, and CT18. (B) FcRII-BI and
-B2, and the B2 tyrosine to alanine mutants A26, A43, and A26&
43. (C) FcRII-B1 and -B2, and the Bl insert mutants B2/BIR and
B2/BIW.
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Receptor
Gold in coated pits
and vesicles (relative)
Gold in coated pits
and vesicles (percent)
Total gold
counted (number)
Average number of
receptors per cell
B2 100 7.7 851 0.7 x 10,
B1 0 0.0 2254 4.0 x 105
B2 CT31 40 3.1 2605 2.1 x 10,
B2 CT18 7 0.53 2447 1 .2 x 10,
B2 tail-minus 7 0.52 2290 2.6 x 10,
B2 A26 86 6.6 1014 1 .1 x 105
B2 A43 78 6.0 1095 7.4 x 105
B2 A26&43 73 5.6 1176 3.5 x 105
B2/Bl-R 6 0.44 2250 6.7 x 10,
B2/B1-W 92 7.1 1084 1 .6 x 10,either wild type FcRII-B2 or the CT31 deletion mutant
mediated rapid internalization of the IgG-complexes, with
uptake being complete within 5 min after warming. In con-
trast, cells expressing the CT18 or tail-minus deletion mu-
tants exhibited little if any ligand. Thus, using the HRP-
complex assay for endocytosis, the differences between B2
and tail-minus transfectants were much more pronounced
than observed using the previously described protease-
release assay which was shown to remove surface-bound
IgG-complexes only inefficiently (Miettinen et al ., 1989) .
The HRP-complex uptake data also yielded kinetics for
FcRII-B2 (and CT31) uptake that were very similar to IgG-
complex endocytosis by B2-expressing macrophages (Mell-
man and Plutner, 1984) .
As indicated by the immunofluorescence experiments,
cells expressing the A26 or A43 tyrosine mutants were also
capable of rapid internalization of bound ligand, although
the rate ofuptake was slowed slightly (but significantly) rela-
tive to FcRII-B2 (Fig. 3 B) . Interestingly, this rate was fur-
ther slowed in the case of the double tyrosine mutant (A26
and 43) to <50 % ofthe B2 wild type. Nevertheless, even the
double mutant-mediated internalization ofthe IgG-complexes
at a rate many-fold greater than the tail-minus deletion mu-
tant or FcRII-BI (Fig. 3 B) . The results of the biochemical
experiments further supportthe suggestionthatthe conserved
region (residues 18-31) of the FcRII-B2 cytoplasmic domain
atleastin partcontains a determinantthat is requiredforrapid
endocytosis. Moreover, they indicate that the tyrosine resi-
due within this region itself is at best only partially required.
While elimination of both cytoplasmic domain tyrosines re-
duced the internalization rate significantly, it was clear that
the effect of this mutation was far less than complete.
FcRII Tyrosine Residues AreNotRequiredfor Coated
PitLocalization
We have previously found that the endocytosis of IgG-
complexes by FeRII-transfected CHO cells can proceed in
part by a coated pit-independent mechanism resembling
phagocytosis. Therefore, to determine whether the im-
munofluorescence and biochemical assays for endocytosis
reflected the abilities of the different FcRII mutants to ac-
cumulate at coated pits, we next measured coated pit local-
ization directly using quantitative EM. Monolayers were in-
cubated at 0°C with gold-conjugated IgG-complexes,
washed, warmed to 37°C for 1.5 min, and then fixed in
glutaraldehyde. For each transfectant, the following param-
eters were analyzed from a minimum of 0.75 mm total cell
surface contour length: the total number of gold particles,
the number of gold particles in coated pits and coated vesi-
cles, and the number of coated pits and coated vesicles. The
percent of totalgold found in coated pits was determined and
the efficiency of coated pit localization expressed relative to
cellsexpressing the FcRII-B2 wild type. Binding wasjudged
to be specific since cell-associated gold was reduced >90%
by simultaneous incubation with the anti-FcRII antibody
2ÁG2 (Miettinen et al., 1989). The number (or area) of
coated pits per cell was not significantly different among the
various cell lines. The results are summarized in Table I.
As found previously, CHO cells expressing FcRII-B2 ac-
cumulated 7.7% ofthe gold IgG-complexes in coated pits af-
ter 1.5 min at 37°C. This extent ofcoated pitlocalization was
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similar to that found for FcRII in macrophages (Ukkonen et
al., 1986 ; unpublished results) as well as for transferrin
receptor in fibroblasts (Miller et al., 1991). The various
FcRII-B2 tyrosine mutants A26, A43, and A26 and 43, were
similar to the wild type receptor with 6.6%, 6.0% and 5.6%
of the total gold-IgG complex in coated pits, respectively.
Thus, relative to cells transfected with FcRII-B2, these cell
lines were 73-86% as efficient at coated pit localization.
These results are in agreement with the immunofluorescence
and endocytosis data suggesting that the loss of one or both
tyrosine residues had only a minor or incomplete effect on
internalization of ligand.
Cells transfected with the FcRII-B2 deletion mutants,
however, exhibited decreased abilities to accumulate gold-
labeled ligand in coated pits. CT31, the mutant lacking the
last 16 amino acids (including the tyrosine at position 43),
exhibited a significant but incomplete defect. As shown in
Table I, this mutant was 40% as efficient at coated pit local-
ization as was full length FcRII-B2 (3.1% of the total gold
incoated pits/vesicles) . Thus,receptorsdevoid ofthe 000H-
terminal third of the cytoplasmic tail were still able to ac-
cumulate at coated pits with significant, but reduced, effi-
ciency. This was in contrast to the endocytosis data which
indicated that CT31 mediated IgG-complex uptake as effi-
ciently as the B2 wild type.
More dramatic, and consistent with the biochemical data,
was the phenotype exhibited by cells expressing the CT18
mutant, whose cytoplasmic tail was deleted through the re-
gion of homology between the human and mouse receptors.
The CT18 transfectants were as inefficient at coated pit local-
ization as cells transfected with the tail-minus mutant. In
both cell lines, only 0.5 % of the gold was found at coated
regions, corresponding to 7 % of the efficiency of the FcRII-
B2 transfectants (Table I). Thus, deletion of residues 18-31
reduced the ability of the receptor to localize at coated pits
as much as a complete truncation of cytoplasmic tail. While
these results indicate that the conserved region is important
for coated pit localization, they do not exclude the possibil-
ity that other regions ofthe cytoplasmic tail also play a role,
particularly since the CT31 mutant had a partial effect on
coated pit localization as did the elimination of both tyrosine
residues.
FcRI1-BI Insert Actively Prevents Coated
PitLocalization
We previously found that the lymphocyte isoform of FcRII
(FcRII-Bl) does not localize in coated pits and is poorly in-
ternalized (Miettinen et al., 1989) . FcRII-B1 is identical to
FcRII-B2 except for an insertion of additional 47 amino acids
that lengthens its tail to 94 residues (Fig. 1) . Having found
that the insert occurs in a region of the cytoplasmic tail that
was not clearly required for coatedpit localization, itbecame
of interest to further characterize how the FcRII-B1 insert
abolished endocytosis.
The insert might prevent accumulation at coated pits by an
active mechanism or by somehow masking or disrupting the
coated pit localization determinant. Given that FcRII-Bl is
much less efficient at coated pit localization than the tail-
minus mutant (Table I) (Miettinen et al., 1989), it seemed
likely that the insert worked via an active mechanism. If so,
the insert might exert an inhibitory effect regardless ofits po-
880sition in the cytoplasmic tail . To test this possibility, we con-
structed a receptor containing the entire FcRII-B2 cytoplas-
mic domain with the Bl insert added to its COOH terminus .
A unique MluI restriction site was first created at the end of
the B2 coding sequence by site-directed mutagenesis . This
mutation changed the two last amino acids (histidine and
isoleucine) to threonine and arginine (Fig . 1) . By im-
munofluorescence in COS-1 cells, this change did not affect
endocytosis of the receptor (not shown) . The BI insert was
then synthesized by polymerase chain reaction and cloned at
the Mlul site either in the right (B2/Bl-R) or in the wrong
(B2/Bl-W) orientations (Fig . 1) . We next established stable
CHO cell lines expressing the receptors and determined
their ability to internalize and degrade IgG-complexes.
Addition of the BI insert to the COON terminus ofFcRII-
B2 (B2/Bl-R) significantly slowed the rate of ligand uptake
relative to FcRII-B2 . As shown in Fig . 3 C, cells transfected
with the B2/Bl-R were as inefficient at ligand uptake as
FcRII-Bl . The inhibition was not due simply to the presence
ofadditional amino acid residues at the FcRII-B2 COOH ter-
minus . This was demonstrated by the fact that cells trans-
fected with a receptor containing the insert in the wrong
orientation (B2/Bl-W), a construct that yielded 19 random
amino acids at its COON terminus, had an internalization
rate thatwas indistinguishable from cells transfected with the
FcRII-B2 wild type (Fig . 3 C) .
To determine whether the different behavior of these
receptors was due to differences in their abilities to localize
in coated pits, we next directly assayed coated pit localization
by EM . As expected from the endocytosis data, cells ex-
pressing the B2/Bl-W construct mediated coated pit localiza-
tion at an efficiency comparable to the FcRII-B2 wild type
(Fig . 4 A and Table I) . In contrast, the B2/Bl-R mutant ex-
hibited a marked reduction in coated pit localization (Fig . 4
B) . Only 0.44% of the total gold was found in coated pits
after 1.5 min at 37°C, corresponding to a 17-18-fold decrease
in efficiency relative to wild type (Table I) . Thus, the FcRII-
B1 insert prevented receptor localization in coated pits ir-
respective of its position in the cytoplasmic tail, suggesting
that the insert contains information that actively prevents the
receptor from accumulating in coated pits .
FcR11-BI Insert Causes Receptor
Alignment with ActinFilaments andEntry
into aDetergent-insoluble Fraction
The FcRII-B1 insert might prevent coated pit localization in
one oftwo ways, either by selectively excluding the receptor
from coated pits or by retaining the receptor at uncoated
regions of the plasma membrane . Conceivably, such a
"retention signal" might work by tethering FcRII-B1 to the
cytoskeleton . We had previously observed that a fraction of
Figure 4. Distribution of gold-labeled IgG-complexes in transfected CHO cells. CHO cells expressing either FcRII-B2/Bl-R or B2/Bl-W,
chimeric receptors containing the FcRII-B1 insertion at their COOH-terminals in the right (R) or wrong (W) orientations, were grown
in 22-nun wells and incubated with 20 ug/ml gold-conjugated IgG complexes for 2 h at 0°C . After washing with PBS-glucose to remove
unbound ligand, the tissue culture plates were dipped for 1.5 min into complete prewarmed (37°C) medium, immediately fixed in glutaral-
dehyde, and processed for thin section EM . (A) Cells expressing the B2/Bl-W chimera had numerous gold particles is coated pits and coated
vesicles (7.1% of the total cell-associated gold, summarized in Table I) . (B) Gold particles were only rarely found in cells expressing the
B2/Bl-R receptor construct (0.44% of the total, see Table I) . Bar, 0.2 lm .
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88 1ligand bound to FcRII-B1 on the cell surface formed linear
arrays afterincubation at 37°C (Miettinen et al., 1989), sug-
gesting a possible cytoskeleton association. This staining
pattern was never observed in cells expressing FcRII-B2 or
the endocytosis-defective CT18 or tail-minus mutants. Thus,
the linear arrays did not simply reflect poor internalization,
but were specific for FcRII-Bl.
We next determined whether cells expressing the FcRII-
B2 constructs with the COOH-terminal BI insert in the right
(B2/Bl-R) or wrong (B2/BI--W) orientations also exhibited
the linear arrays and whether the arrays corresponded to any
cytoskeletal element. Transfected CHO cellswere incubated
with prebound IgG-complexes for 1 h at 37°C, fixed, and
processed for immunofluorescence. As shown in Fig. 5, cells
expressing either FcRII-131 or the B2/Bl-R mutant (A and C)
clearly showed that a fraction of the receptor-ligand com-
plexes was found in linear arrays. In contrast, cells trans-
fected with B2/Bl-W (E) exhibited a pattern of intracellular
vesicular staining similar to the FcRII-B2 transfectants (Fig.
2 A) . To determine whether the arrays localized with any
cytoskeletal elements, the cells were costained with antibod-
ies against fodrin and tubulin, and with rhodamine-conjugated
phalloidin to visualize F-actin . While the antifodrin and anti-
tubulin staining did not show any colocalization with the lin-
ear arrays, the actin filament staining indeed colocalized
(Fig. 5 B, D, and F), suggesting a direct or indirectinteraction
between the receptor and the actin microfilament network.
To further characterize the interaction, we examined the
time course for the formation of the linear arrays. CHO cells
expressing FcRII-BI were incubated with IgG complexes for
2 h at 0°C, warmed to 37°C for 5, 10, and 20 min, and pre-
pared for immunofluorescence. Although the linear arrays
were not visible at 5 min, they began to appear after 10 min
at 37°C and to colocalize with actin (Fig. 6). Thus, the puta-
tive interaction between FcRII-BI and cytoskeleton was both
time and temperature dependent.
If the FcRII-Bl insert specified an interaction between the
receptor and the cytoskeleton, it might also be expected to
cause receptors containing the insert to become resistant to
detergent extraction. To determine if this was the case, cells
were labeled with [3'S]cysteine and then placed on ice for 2
h or incubated for 30 min at 37°C in the presence or absence
of ligand (IgG-complexes or polyclonal anti-FcRII anti-
body). The cells were washed with PBS and extracted on ice
for 10 min with 0.5% Triton X-100 (Fey et al ., 1984) .
Monolayers were scraped with a rubber policeperson and the
detergent-insoluble fraction was pelleted by centrifugation.
The pellet was then solubilized with SDS, and FeR immuno-
precipitated.
As shown in Fig. 7 A, when CHO cells expressing FcRII-
Bl were incubated in the absence of ligand at 0°C, labeled
receptor was not precipitated from the Triton X-100 insolu-
ble fraction (lanes 1 and 2); similar results were obtained for
cells incubated at 37°C without ligand (not shown) . If IgG-
complexes were added to the cells at 0°C, a small fraction
of the receptor could be precipitated from the insoluble pool
(lanes 3 and 4) . However, incubation with IgG-complexes or
rabbit anti-FcR antibody at 37°C resulted in the recovery of
25-35% of the total FcRII-BI from the detergent insoluble
fraction (lanes S-8, arrowhead). Similar results were ob-
tained when the cellswere first incubated 2 h on ice with the
ligand and then warmed up to 37°C for 30 min (not shown).
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Thus, in agreement with the conditions required for the for-
mation of linear receptor arrays, appearance of FcRII-Bl in
the detergent-insoluble fraction was both ligand and temper-
ature dependent. It also occurred rapidly, with kinetics that
were similar to the appearance of the linear arrays. As shown
in Fig. 7 B and C, Triton-insoluble receptor was barely de-
tectable after 5 min at 37°C, but reached a plateau after
10 min.
Importantly, detergent-insoluble receptor was not detected
in cells expressing FcRII-B2 even after prolonged incuba-
tions under any conditions (0°C or 37°C, in the presence or
absence of either ligand) (Fig. 7 A, lanes 9-12). However,
a significant amount (-30%) the FcRII-B2 construct con-
taining the FcRII-131 insert at its COOHterminus (B2/Bl-R)
was recovered from the Triton-insoluble fraction after incu-
bation with ligand at 37°C (lanes 13 and 14). The FcRII-B2
construct containing the insert in the wrong orientation re-
mained Triton-soluble (lanes IS and 16). Thus, the presence
of the FcRII-B1 insert-at the proximal or distal regions of
the cytoplasmic tail-resulted in the ligand and temperature-
dependent association of the receptor with a detergent-insol-
uble fraction expected to contain the cytoskeleton .
Discussion
Analysis of naturally occurring variations in the FcRI1 cyto-
plasmic tail has begunto reveal how alternative mRNA splic-
ing can determine the function ofplasma membrane proteins
(Amigorena, S., C. Bonnerot, D. Choquet, G. Raposo, J.G.
Guillet, C. Sautes, W H. Fridman, J. Drake, W. Hunziker,
P Webster, and I. Mellman, manuscript submitted for publi-
cation; Hunziker et al., 1990; Joiner et al., 1990; Miettinen
et al., 1989). Evidence presented in this paper suggests that
although FcRII isoforms with distinct abilities for endocy-
tosis both contain an intact coated pit localization domain,
its function is specifically inactivated by the sequence inser-
tion in FcRII-Bl. Moreover, the coated pit localization do-
main itself appeared to be somewhat different from that typi-
cally associated with endocytic receptors.
The three other receptors (LDL-, mannose-6-phosphate-,
and transferrin receptors) whose coated pit localization do-
mains have been studied in greatest detail were each found
to contain a cytoplasmic tail tyrosine whose presence was
strongly required for rapid endocytosis and/or accumulation
at coated pits (Alvarez et al., 1990; Davis et al., 1987; Gi-
ronès et al., 1991; Jing et al ., 1990; Lobel et al ., 1989;
McGraw and Maxfield, 1990). In each case, alteration of a
single tyrosine residue reducedthe rate or efficiency ofendo-
cytosis by 5-20-fold. For LDL and transferrin receptors, this
decrease was also found to reflect a similar decrease in re-
ceptor accumulation at coated pits. There is ample evidence
thatthese tyrosines formpart ofan as yet incompletely under-
stood sequence motifwhose secondary structure is thought
to represent a recognition site for adaptor or assembly pro-
teins found in clathrin-coated pits (Pearse and Robinson,
1990) .
The FcRII-B2 cytoplasmic tail contains two tyrosines at
positions 26 and 43, and no other aromatic amino acids. Y26
was the best candidate for a residue critical for coated pit lo-
calization for two reasons. First, it was found within the only
region of the cytoplasmic tail that is highly conserved be-
tween murine and human FcRII (Stuart et al., 1989). Sec-
882Figure 5 . Fc receptors containing the FCRII-B1 insert form linear arrays that colocalize with F-actin. Stably transfected CHO cells were
incubated2 h at 0°C with 20 pg/ml IgG-complexes, washed, andthen warmed in complete medium to 37°C . After30 min, the cells were
fixed with paraformaldehyde-lysine-periodate andpermeabilized with saponin . Receptor-ligand complexes were visualized using F(ab')z
fluorescein-conjugated goat anti-rabbitIgG and actin filaments using rhodamine-conjugated phalloidin . (A) FcRII-BI, IgG-receptor com-
plexes ; (B) FcRII-Bl, actinfilaments;(C)FcII-B2Bl-R, IgG-receptor complexes;(D) FcRII-B2/Bl-R, actin filaments ; (E)FcRII-B2B1--W,
IgG-receptor complexes ; (F) FcRII-B2/Bl-W actin filaments .
ond, thesequences surroundingY26are at least superficially
similar to sequencesfound in othercoated pit receptors . One
recent secondary structure prediction suggests that the
residues on theamino-terminal side of the tyrosine tends to
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be a random coil that may form a salt bridge with polar
residues just downstream of the tyrosine (Ktistakis et al .,
1990). TheNPXY sequence motifdefined as important for
the LDL receptor coated pit localization domain (Chen et
883Figure 6. Time course for formation of linear arrays in CHO cells expressing FcRII-Bl . Cells were incubated for 2 h at 0°C in medium
containing 20 gg/ml IgG complexes, washed, and warmed to 37°C for 5, 10, or 20 min before fixation . Fixed cells were permeabilized
with saponin and incubated with fluorescein-conjugated goat anti-rabbit IgG to visualize receptor-bound ligand (A, C, and E) and with
rhodamine-conjugated phalloidin to visualize actin filaments (B, D, and F) . (A and B) 5 min ; (C and D) 10 min ; (E and F) 20 min .
al ., 1990) is included in this prediction . While not as
strongly predicted, the sequence around Y26 (Fig . 1) pos-
sessed the expected features (Ktistakis et al., 1990) .
We were thus surprised to find that changing either Y26
or Y43 to alanines only slightly decreased the rate of IgG-
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complex internalization and did not appreciably decrease the
efficiency ofcoated pit localization . Changing both tyrosines
simultaneously, interestingly, did reduce endocytosis by
-50% . This decrease did notreflect a major reduction in the
frequency of FcRII localization at coated pits, which re-
884Figure 7 . Immunoprecipitation ofFcRII from insolubleand soluble fractions of Triton X-100 extracted CHO transfectants. Cells were la-
beled with "S-cysteine, washed, chased for 1 h at 37°C, and incubated for an additional 30 min at 0°C or 37°C with or without20 Ag/ml
IgG-complexes or amonospecific polyclonal rabbit anti-FcRII serum (1:100 final dilution).The cultures were washed withcold PBS-glucose
and extracted with 0.5% Triton X-100 in 10 mM K-Pipes, pH 6.8, 100 mM NaCl, 300mM sucrose, 3MM M9CIZ , and 1 mM PMSF
(Fey etal ., 1984). LabeledFcRIlwasthen immunoprecipitated from both the TritonX-100 soluble and insoluble fractions (after solubiliza-
tion in SDS) using a rabbit anti-FcRÜ serum . The precipitated samples were treated with N-glycanase and then analyzed by SDS-PAGE
andautoradiography. Autoradiographswere quantified usingaKodak Visage 2000 image processor. Since FCRII normally runs as a diffuse
glycoprotein band after SDS-PAGE, the glycosidase treatment was used to facilitate quantitation . Themigration of molecular weight mark-
ers (10-3) is shown at left . (A) Triton X-100 solubility of FcRIIand FcRII (arrows) in the presence or absence of ligand at 0°C and 37°C.
IgGC, IgG complexes ; Rb anti-FcR, rabbit anti-FcRII anti-serum; i, insoluble; s, soluble. (lanes 1-8) cells transfected with FcRII-Bl ;
panes 9-12) FcRII-B2 ; (lanes 13 and14)FcRII-B2/Bl-R ; (lanes 15 and 16) FcRII-B2/Bl-W (B) Timecourse ofappearance ofTriton X-100
insolubility of FCRII-BI after exposure to IgG-complexes at 37°C. (C) Quantitation of the autoradiogram shown in B.
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885mained at 80% ofcontrol. Moreover, endocytosis by the Y26
and 43 FcR111 mutant was considerably less affected than ob-
served for mutations of even multiple tyrosines (or aromatic
amino acids) in other receptors such as the transferrin, poly-
meric immunoglobulin, and cation-dependent mannose-6-
phosphate receptors (Breitfeld et al ., 1990; Giron6s et al.,
1991; Johnson et al ., 1990) . This was true even for the
asialoglycoprotein receptor in which deletion of the single
cytoplasmic tail tyrosine only partially eliminated coated pit
localization and endocytosis, but nevertheless reduced both
by approximately threefold (Fuhrer et al., 1991). Although
the synergistic effect of altering Y26 and Y43 together is
consistent with there being at leasttwo regions of the FcRII
cytoplasmic domain which may be involved in coated pit lo-
calization, as suggested for the cation-dependent mannose-
6-phosphate receptor, it would appear that tyrosine residues
may have a relatively reduced importance in FcRII relative
to most other receptors. However, the lack of an absolute de-
pendence on the presence of a tyrosine residue appears to be
amoregeneral phenomenon thathad originally been thought.
Analysis of the deletion mutants suggested that the cyto-
plasmic tail did appear to contain specific regions that were
required for coated pit localization. Perhaps the most impor-
tant was a 13 residue segment containing Y26 and corre-
sponding to the region of homology between the humanand
mouse receptors. Truncationofthe cytoplasmic tail up to the
homologousregion (CT31) did not decrease the rate of IgG-
complex internalization . It did causea partial but significant
decrease in coated pit localization (40% relative to FcRII-B2
wild type). The reason for the disparity between the bio-
chemical and morphological assays is unclear, but may
reflect the difficulties and variability inherent to quantitative
EM: it should also be emphasized that quantitative correla-
tions between biochemistry and EM has been attempted for
few other receptors. The possible role of variation in the
morphological assay is emphasized by the fact that deletions
(CT18) removing the entire homologous region reduced both
endocytosis and coated pit accumulation to levels identical
to that of a mutant lacking the entire cytoplasmic tail. Thus,
the region between amino acids 19-31 may play a more im-
portant role in specifying coated pit localization than the first
18 or the COOH-terminal 16 amino acids. However, deletion
mutations causing loss of function cannot be used alone to
identify this domain definitively.
Taken together, these results suggest that FcRII-B2 con-
tains a coated pit localization domain that does not require
a tyrosine or other aromatic amino acid for activity. The ex-
istence of a second, tyrosine-independent signal may reflect
the fact that receptors such as FcRII-B2 are not constitutively
concentrated at coated pits. For example, up to 70% of all
LDL receptors can be foundin coated pits which account for
only 2-3% of the cell surface (Anderson et al., 1982). On
the other hand, when determined by thin section EM, only
6 % of total transferrin receptors or asialoglycoprotein
receptors in fibroblasts are found at coated pits (Fuhrer et
al., 1991; Miller et al., 1991). FcRII are more evenly dis-
tributed and may accumulate at coated pits only after binding
multivalent IgG-complexes (Miettinen et al., 1989; Ukko-
nen et al., 1986) . When FcRII distribution is visualized using
monovalent antireceptor Fab-gold conjugates on glutaralde-
hyde-fixed cells, no more than 1% of the receptors are found
in coated pits (unpublished results). Thus, the FcRII-B2
coated pit localization domain may be subject to regulation,
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its activity being enhanced by ligand binding. This may also
hold for other receptors, e.g., polypeptide growth factors,
whose internalization may also be regulated by ligand bind-
ing. The coated pit localization domains of growth factor re-
ceptors have not yet been precisely defined, thus it is not
clear what type of coated pit localization determinant is
used. Interestingly, EGF receptorhas three consensus NPXY
sequences in the distal segment of its >500 residue cytoplas-
mic tail (Ullrich, 1984). Deletion of this segment, however,
has no effect on the rate of EGF endocytosis (Chen et al.,
1989).
Irrespective of the number or types ofcoated pit localiza-
tion domains that are ultimately identified, it can be assumed
that they must all directly or indirectly be recognized by one
or more components of coated pits. Conceivably, all com-
pete for the same pit components. In this case, each domain
should have structural features in common, regardless of the
role of tyrosine, possibly explaining the predicted relation-
ship of the FcRII-B2 sequence to tyrosine-containing signals
(Ktistakis et al., 1990). An appealing possibility is that the
common element of this structure may be a tight turn, based
on an analysis of a crystallographic data base (Collawn et
al., 1990).
A Signal That Blocks Endocytosis and
Coated Pit Localization
It is clear that the function of the FcRII-B2 coated pit local-
ization domain is abrogated by the FcRII-BI insertion (Miet-
tinen et al., 1989). Our results now show this effect to be
more a function of the insert itself than of its location in the
FcRII tail . In murine and human FcRII, alternative splicing
places the insert at an intron-exon junction corresponding to
residue 6 of the murine cytoplasmic tail (Qiu et al ., 1990).
Sincethis site is 12 residues away from a presumptive coated
pit localization domain (i .e., residues 19-31), its effect is not
due to physical disruption . This is consistent with the recent
finding that only sequences corresponding to the amino-ter-
minal half of the insertion are capable of blocking endocy-
tosiswhen inserted at position 6 in the FcRII-B2 cytoplasmic
domain (Matter, K., and I. Mellman, unpublished observa-
tions). Since the COOH-terminal half of the insertion alone
is without effect, it is apparent that specific, as opposed to
random, sequences must be present at position 6 in orderto
mediate the block in coated pit localization. The insertion
does not haveany obvious sequencehomology to other known
proteins, however.
Moreover, transplanting the insert to the COON terminus
of the FcRII-B2 tail (B2/Bl-R) resulted in an almost com-
plete inhibition of coated pit localization . The B2/Bl-R con-
struct was somewhat less efficient than FcRII-Bl, however,
suggesting that the insert's position in the tail may have some
role in determining its effect. Nevertheless, these results
show that the insertion contains information that is necessary
and sufficient to prevent FcRII localization at coated pits.
It was also clear that the FcRII-Bl insertion must do more
than simply inactivate the FcRII-B2 coated pit localization
domain. Removal of the domain, as in the tail-minus or CT18
mutants, reduced the frequency of coated pit localization to
7% ofcontrol, presumably reflecting random distribution of
receptor. In the FcRII-Bl transfectants, however, virtually no
receptor was observed associated with coated pits out ofover
2,250 gold particles counted . Thus, FcRII-111 must be either
886selectively excluded from entering coated pits or actively re-
tained in uncoated regions of the plasma membrane. Given
that the insert also appeared to cause the receptor to associ-
ate with the cytoskeleton-or at leastto align with actin fila-
ment and to enter a detergent-insoluble fraction-its effect
may be thought of as a "retention signal" that prevents the
receptor from entering coated regions. This possibility was
supported by the fact that the appearance of FcRII-Bl in the
detergent insoluble fraction apparently occurred almost as
fast (t,/2 -5 min) as FcRII-B2-mediated endocytosis. Al-
though ligand-induced association with the cytoskeleton
may occur rapidly enough to interfere with the ligand-in-
duced accumulation ofthe receptor at coated pits, we cannot
yet conclude that this is the mechanism by which the insert
blocks internalization. Instead, the insert might allow the
receptor to interact with another protein which is already ex-
cluded from coated pits, with cytoskeletal attachmentofthis
complex occurring as a secondary phenomenon . If this pos-
sibility is true, then a region ofthe FcRII-BI cytoplasmic do-
main other than the insert itself may actually be responsible
for detergent insolubility. This possibility is consistent with
preliminary results showing that cytoskeletal attachmentre-
quires not just the insert but sequences distal to the insert
(Matter, K., and I. Mellman, unpublished data).
Several receptors and nonreceptor plasma membrane pro-
teins are already known to associate with the cytoskeleton.
In nucleated cells, one of the best characterized examples is
the Na+,K+-ATPase which binds to fodrin in conjunction
with ankyrin and uvomorulin in kidney epithelial cells
(McNeill et al., 1990; Morrow et al., 1989; Nelson and
Veshnok, 1987) . As in the case of FcRII-BI, the detergent-
insoluble fraction is incomplete (20-50%) depending on the
degree of cell confluence or cell polarity. The fact that
<100 % of a membrane protein can be recovered as insoluble
suggests that association with the cytoskeleton is a dynamic
event, with. individual receptors continuously forming and
breaking the associations that lead to detergent insolubility.
In support of this possibility are preliminary experiments in
which living cells expressing FcRII-BI were viewed by dif-
ferential interference contrast microscopy. Individual ligand-
conjugated gold particles were found to exist in two states
on the plasma membrane, the firstcorresponding to restricted
linear movements and the second to apparently random dif-
fusion in all directions (unpublished data) . While more di-
rect evidence will be required to establish that FcRII-BI ac-
tually binds directly or indirectly to one or more elements
of the cytoskeleton, it is interesting that the fraction of the
receptor that is recovered in the detergent-insoluble fraction
can be increased significantly (greater than twofold) by per-
forming the extraction in the presence ofphalloidin, an agent
that stabilizes actin filaments (Matter, K., and I. Mellman,
unpublished data) .
Our results show that alternative splicing can regulate a re-
ceptor's ability to internalize ligand via clathrin-coated pits
apparently by introducing a sequence that binds the receptor
to the cytoskeleton. While we have used transfected fibro-
blasts, it is very likely that the insert performs an analogous
function in B-cells where FcRII-BI is normally expressed.
Most B-cells and B-cell lines express high levels of FcRII-BI
which plays an important role in regulating surface immuno-
globulin-induced B-cell activation (Bijsterbosch and Klaus,
1985; Phillips, 1984) . These cellsare incapable ofinternaliz-
ing and degrading receptor-bound IgG-complexes or of pre-
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senting IgG-conjugated antigen to T-cells (Amigorena et al.,
1991). Significantly, transfection of FcRII-B2 into receptor-
negative B-cell mutants completely corrects both of these
"defects." Since FcRII-B1 typically cocaps with cross-linked
surface immunoglobulins, and since cap formation is accom-
panied by a local reorganization of cytoplasmic actin and ras
(Graziadei et al., 1990), it is possible that the receptor's abil-
ity to interact with the cytoskeleton plays a role in the for-
mation or function of the cap itself.
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